These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 39375177)
1. Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID. Kummer LYL; Fernández Blanco L; Kreher C; Bos A; Kuijper LH; Verstegen NJM; van de Sandt CE; Konijn VAL; Duurland MC; Menage C; Jorritsma T; Steenhuis M; Hagen RR; van den Dijssel J; de Jongh R; Ashhurst T; van Gils MJ; Garcia-Vallejo JJ; Claireaux M; Stalman EW; van Dam KPJ; Wieske L; Boekel L; Wolbink G; Tas SW; Rispens T; Kuijpers TW; Eftimov F; van Ham SM; Ten Brinke A; RMD Open; 2024 Oct; 10(4):. PubMed ID: 39375177 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
3. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
4. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults. Huang Y; Trollor JN; Foley KR; Arnold SRC Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050 [TBL] [Abstract][Full Text] [Related]
6. Severe acute respiratory syndrome coronavirus 2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination. Wang X; Li Y; Jin J; Chai X; Ma Z; Duan J; Zhang G; Huang T; Zhang X; Zhang T; Wu H; Cao Y; Su B Chin Med J (Engl); 2024 Nov; 137(22):2734-2744. PubMed ID: 39028115 [TBL] [Abstract][Full Text] [Related]
7. Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. Liu X; Munro APS; Wright A; Feng S; Janani L; Aley PK; Babbage G; Baker J; Baxter D; Bawa T; Bula M; Cathie K; Chatterjee K; Dodd K; Enever Y; Fox L; Qureshi E; Goodman AL; Green CA; Haughney J; Hicks A; Jones CE; Kanji N; van der Klaauw AA; Libri V; Llewelyn MJ; Mansfield R; Maallah M; McGregor AC; Minassian AM; Moore P; Mughal M; Mujadidi YF; Belhadef HT; Holliday K; Osanlou O; Osanlou R; Owens DR; Pacurar M; Palfreeman A; Pan D; Rampling T; Regan K; Saich S; Saralaya D; Sharma S; Sheridan R; Stokes M; Thomson EC; Todd S; Twelves C; Read RC; Charlton S; Hallis B; Ramsay M; Andrews N; Lambe T; Nguyen-Van-Tam JS; Cornelius V; Snape MD; Faust SN; J Infect; 2023 Jul; 87(1):18-26. PubMed ID: 37085049 [TBL] [Abstract][Full Text] [Related]
8. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
9. Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial. Dumoulin QA; Krijbolder DI; Visser K; Lard LR; van der Helm-van Mil AHM Lancet Rheumatol; 2024 Dec; 6(12):e827-e836. PubMed ID: 39303731 [TBL] [Abstract][Full Text] [Related]
10. Polysaccharide, Conjugate, and mRNA-based Vaccines are Immunogenic in Patients with Netherton Syndrome. Nouwen AEM; Zaeck LM; Schappin R; Geers D; Gommers L; Bogers S; Dik WA; Pasmans SGMA; GeurtsvanKessel CH; de Vries RD; Dalm VASH J Clin Immunol; 2024 Oct; 45(1):36. PubMed ID: 39476295 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study. Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N Hum Vaccin Immunother; 2024 Dec; 20(1):2408863. PubMed ID: 39422261 [TBL] [Abstract][Full Text] [Related]
12. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
15. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]
16. Strategies to improve smoking cessation rates in primary care. Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994 [TBL] [Abstract][Full Text] [Related]
17. Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY. Pearce FA; Lim SH; Bythell M; Lanyon P; Hogg R; Taylor A; Powter G; Cooke GS; Ward H; Chilcot J; Thomas H; Mumford L; McAdoo SP; Pettigrew GJ; Lightstone L; Willicombe M Lancet Rheumatol; 2023 Aug; 5(8):e461-e473. PubMed ID: 38251578 [TBL] [Abstract][Full Text] [Related]